COVID-19 Updates
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
Conference Coverage
Chest pain with long COVID common but undertreated
“Our current analysis indicates that chest pain continues on for years in many individuals, suggesting that COVID-related chest pain may be...
Conference Coverage
Saltwater gargling may help avoid COVID hospitalization
Hospitalization rates in the low- (18.5%) and high- (21.4%) saline groups were significantly lower than in the reference control population.
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
Feature
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.
From the Journals
People with long COVID don’t show signs of brain damage
“The findings thus suggest that post-COVID condition is not the result of ongoing infection, immune activation, or brain damage.”
From the Journals
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
However, thromboembolic events were reduced.
News
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...
From the Journals
COVID coronary plaque infection confirms CV risk
The findings may not only explain the link between COVID and the increased risk of cardiovascular events but mark a starting point for new...
From the Journals
Paxlovid tied to benefits in high-risk patients with COVID
No significant benefit was observed in patients who were not immunocompromised.